#1蛋 AIB Investor Presentation - AT1 16 Jun 2020 AIB Group plc#2Disclaimer AIB NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR TO ANY PERSON OR ADDRESS IN THE U.S. IMPORTANT: You must read the following before continuing. The following applies to the presentation materials contained in this document, and you are therefore advised to read this carefully before reading, accessing or making any other use of the presentation materials. In accessing the presentation, you agree to be bound by the following terms and conditions, including any modifications to them any time you receive any information from us as a result of such access. This presentation is not a prospectus, listing particulars or offering memorandum and investors should not subscribe for or purchase any Securities (the "Securities") referred to in this presentation except on the basis of the information in the listing particulars to be prepared and published by the Issuer in relation to the Securities (the "Listing Particulars"). This investor presentation has been prepared by AIB Group plc (the "Issuer"). This presentation is for informational purposes only and does not constitute or form part of, and should not be construed as, an offer, invitation or inducement to purchase or subscribe for any Securities nor shall it or any part of it form the basis of, or be relied upon in connection with, any contract or commitment whatsoever. No person shall have any right of action (except in case of fraud) against the Issuer or any other person in relation to the accuracy or completeness of the information contained herein or in any other document made available in connection with the transaction described in this presentation (the "Transaction") or the Securities. The information contained in this presentation has not been independently verified. None of J.P. Morgan Securities plc, Goldman Sachs International, Goodbody Stockbrokers UC, Merrill Lynch International, NatWest Markets N.V. and UBS Europe SE (together, the "Managers") or their respective affiliates, agents, directors, partners and employees accepts any responsibility whatsoever for, or any liability for any loss howsoever arising, directly or indirectly, from this presentation or its contents, or makes any representation or warranty, express or implied, as to the contents of this presentation or for any other statement made or purported to be made by it, or on its behalf, including (without limitation) information regarding the Issuer or the Securities and no reliance should be placed on such information. To the fullest extent permitted by applicable law, the Managers accordingly disclaim any and all responsibility and/or liability, whether arising in tort, contract or otherwise, which they might otherwise have in respect of this presentation or any such statement. This presentation should not be considered as a recommendation that any investor should subscribe for or purchase Securities, and must be read together with the Listing Particulars. Any person who subsequently acquires Securities is advised to read the Listing Particulars carefully and must not rely on any information contained in this presentation, which is subject to amendment, revision and updating. In particular, investors should pay special attention to any sections of the Listing Particulars describing the relevant risk factors. The merits or suitability of the Transaction and the Securities described in this presentation to any investor's particular situation should be independently determined by such investor. Any such determination should involve, inter alia, an assessment of the legal, tax, accounting, regulatory, financial, credit and other related aspects of the Transaction or the Securities. No person is authorised to give any information or to make any representation not contained in and not consistent with this presentation and the Listing Particulars and, if given or made, such information or representation must not be relied upon as having been authorised by or on behalf of the Issuer. This presentation contains or incorporates by reference certain statements that constitute forward-looking statements. Some statements in this presentation may be deemed to be forward looking statements. Forward looking statements include statements concerning the Issuer's plans, objectives, goals, strategies, future operations and performance and the assumptions underlying these forward looking statements. When used in this presentation, the words "anticipates", "estimates", "expects", "believes", "intends", "plans", "aims", "seeks", "may", "will", "should" and any similar expressions generally identify forward looking statements. The Issuer has based these forward looking statements on the current view of its management with respect to future events and financial performance. Although the Issuer believes that the expectations, estimates and projections reflected in its forward looking statements are reasonable as of the date of this presentation, if one or more of the risks or uncertainties materialise, including those identified below or which the Issuer has otherwise identified in this presentation, or if any of the Issuer's underlying assumptions prove to be incomplete or inaccurate, the Issuer's actual results of operation may vary from those expected, estimated or predicted. 2#3Disclaimer The risks and uncertainties referred to above include: (i) the performance of the markets in Ireland and the wider region in which the Issuer operates; (ii) changes in political, social, legal or economic conditions in the markets in which the Issuer and its customers operate; (iii) the Issuer's ability to achieve and manage the growth of its business; (iv) the Issuer's ability to obtain external financing or maintain sufficient capital to fund its existing and future investments and projects; (v) the Issuer's ability to realise the benefits it expects from existing and future projects and investments it is undertaking or plans to or may undertake; and (vi) actions taken by the Issuer's joint venture partners that may not be in accordance with its policies and objectives. Any forward looking statements contained in this presentation speak only as at the date of this presentation. Without prejudice to any requirements under applicable laws and regulations, the Issuer expressly disclaims any obligation or undertaking to disseminate, after the date of this presentation, any updates or revisions to any forward looking statements contained herein to reflect any change in expectations thereof or any change in events, conditions or circumstances on which any such forward looking statement is based. This presentation is confidential and is being submitted to selected recipients only. If handed out at a physical roadshow meeting or presentation, it should be returned promptly at the end of such meeting/presentation. It may not be reproduced (in whole or in part), distributed or transmitted to any other person without the prior written consent of the Issuer. The information contained in this presentation has not been subject to any independent audit or review. This presentation is not directed or intended for distribution to, or use by, any person or entity that is a citizen or resident located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to the law or regulation of that jurisdiction or which would require any registration or licensing within such jurisdiction. In particular these materials are not intended for distribution in the United States or to U.S. persons (as defined in Regulation S) under the United States Securities Act of 1933, as amended. Persons who come into possession of any document or other information referred to herein should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions. In the United Kingdom, the presentation is being distributed only to, and is directed only at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), and persons falling within Article 49 of the Order, and (ii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). The presentation must not be acted on or relied on in the UK by persons who are not relevant persons. Any investment or investment activity to which the presentation relates is available only to relevant persons in the UK and will be engaged in only with such persons. Restrictions on marketing and sales to retail investors The Securities are complex financial instruments and are not a suitable or appropriate investment for all investors. In some jurisdictions regulatory authorities have adopted or published laws, regulations or guidance with respect to the offer or sale of securities such as the Securities to retail investors. In particular, in June 2015, the United Kingdom Financial Conduct Authority (the "FCA") published the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015, which took effect from 1 October 2015 (the "PI Instrument"). In addition, (i) on 1 January 2018, the provisions of Regulation (EU) No. 1286/2014 on key information documents for packaged and retail and insurance-based investment products ("PRIIPS") became directly applicable in all European Economic Area ("EEA") member states and (ii) the Markets in Financial Instruments Directive 2014/65/EU (as amended) ("MiFID II") was required to be implemented in EEA member states by 3 January 2018. Together, the Pl Instrument, PRIIPs and MiFID II are referred to as the "Regulations". The Regulations set out various obligations in relation to (i) the manufacture and distribution of financial instruments and (ii) the offering, sale and distribution of packaged retail and insurance-based investment products and certain contingent write down or convertible securities, such as the Securities. Potential investors in the Securities should inform themselves of, and comply with, any applicable laws, regulations or regulatory guidance with respect to any resale of the Securities (or any beneficial interests therein), including the Regulations. AIB 3#4Disclaimer By purchasing, or making or accepting an offer to purchase, any Securities (or a beneficial interest in such Securities) from the Issuer and/or any of the Managers, each prospective investor will thereby represent, warrant, agree with and undertake to the Issuer and each of the Managers that: (i) it is not a retail client (as defined in MiFID II); (ii) whether or not it is subject to the Regulations, it will not: (A) sell or offer the Securities (or any beneficial interest therein) to retail clients (as defined in MiFID II); or (B) communicate (including the distribution of the Listing Particulars) or approve an invitation or inducement to participate in, acquire or underwrite the Securities (or any beneficial interests therein) where that invitation or inducement is addressed to, or disseminated in such a way that it is likely to be received by, a retail client (as defined in MiFID II) and in selling or offering Securities or making or approving communications relating to the Securities, it may not rely on the limited exemptions set out in the PI Instrument; and (iii) it will at all times comply with all applicable laws, regulations and regulatory guidance (whether inside or outside the EEA) relating to the promotion, offering, distribution and/or sale of the Securities (or any beneficial interests therein), including (without limitation) MiFID II and any other applicable laws, regulations and regulatory guidance relating to determining the appropriateness and/or suitability of an investment in the Securities (or any beneficial interests therein) by investors in any relevant jurisdiction. Each prospective investor further acknowledges that: (i) the identified target market for the Securities (for the purposes of the product governance obligations in MiFID II) is eligible counterparties and professional clients; and (ii)no key information document (KID) under PRIIPs has been prepared and therefore offering or selling the Securities or otherwise making them available to any retail investor in the EEA may be unlawful under PRIIPS. Prohibition of Sales to EEA and UK Retail Investors - The Securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA or in the UK. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97 (the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by PRIIPs for offering or selling the Securities or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore offering or selling the Securities or otherwise making them available to any retail investor in the EEA or in the UK may be unlawful under PRIIPs. MiFID II product governance / Professional investors and ECPs only target market - Solely for the purposes of each manufacturer's product approval process, the target market assessment in respect of the Securities has led to the conclusion that: (i) the target market for the Securities is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Securities to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Securities (a "distributor") should take into consideration the manufacturers' target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Securities (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels. Where you act as agent on behalf of a disclosed or undisclosed client when purchasing, or making or accepting an offer to purchase any Securities (or any beneficial interests therein) from the Issuer and/or any of the Managers, the foregoing representations, warranties, agreements and undertakings will be given by and be binding on both you and your client(s). AIB#5Disclaimer Singapore: No sales to any person in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time, the "SFA") pursuant to Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. AIB 5#6Contents AT1 Transaction & tender offer - overview Q1 2020 Trading & Covid-19 update Credit ratings Medium term targets Contacts 7 15 19 20 21 AIB 6#7AT1 Transaction & Tender Offer - overview AIB Group plc AIB#8Executive summary " PerpNC [ ] [ ] Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write-Down Securities Issued by AIB Group plc (HoldCo), in line with group structure and resolution strategy Semi-annual, discretionary, non-cumulative coupons • Offering summary • Par call exercisable at any time during the 6 month before the First Reset Date ◉ 7.0% CET1 ratio trigger Issuance rationale Investment thesis AIB • ■ Expected issue rating: Ba2 by Moody's Simultaneous capped EUR 250m tender for the EUR 500m 7.375% PNC Dec-20 as part of the Group's active management of its consolidated capital profile The transaction is part of AIB's ongoing capital management strategy and fulfilment of its current and future capital and resolution requirements " ■ • AIB is committed to optimising its capital structure at AIB Group plc (HoldCo) The transaction further supports AIB's robust leverage ratio, Tier 1 capital ratio, MREL position It will also fund the concurrent capped tender offer on Allied Irish Banks, p.l.c.'s €500mm 7.375% AT1 Notes callable 3-Dec-2020 (up to €250mm) Leading Irish bank, well positioned and planning for the future Strongly capitalised with resilient buffer to principal and coupon risks - FL CET1 ratio 16.2% (1) and transitional CET1 18.6% (¹) at Q1 2020 • Q1 2020: CET1 buffer to trigger of 11.6% / €6.2bn (Trans) Q1 2020: CET1 headroom to MDA of 7.1% / €3.8bn (Trans) Strong liquidity position, diversified sources of funding and smooth maturity profile LCR 155%, NSFR 132% and LDR 83% " Robust ADI capacity in excess of €4.5bn as at 31 Mar 2020 (1) Pro-forma FL CET1 16.2% and pro-forma Transitional CET1 18.6% both include 90bps indicative TRIM impact for AIB mortgage model and 40bps for cancelled 2019 dividend €217m 8#9Mitigating principal write-down risk Robust buffer to trigger Q1, 2020 - Buffer to trigger (FL, %) 16.2% 9.2% RWA €4.9bn CET1 7.0% (1) Pro-forma CET1 ratio Buffer to trigger CET1 ratio trigger AIB Capital position remains particularly strong with 16.2% CET1 ratio fully loaded (18.6% CET1 ratio transitional) (1) at Q1 2020 Temporary write-down loss absorption mechanism ■ 7.0% CET1 ratio trigger Distance to trigger 9.2% RWA / €4.9bn CET1 buffer based on fully loaded Q1 2020 CET1 ratio of 16.2% On a transitional basis, distance to trigger 11.6% RWA / €6.2bn CET1 buffer from Q1 2020 CET1 ratio of 18.6% (1) Pro-forma FL CET1 16.2% and pro-forma Transitional CET1 18.6% both include 90bps indicative TRIM impact for AIB mortgage model and 40bps for cancelled 2019 dividend €217m 9#10CET1 requirements (% RWA) SREP: CET1 & Total capital requirements FY 2020 & 2021 FY 2021 (Pro-forma Article 104a) FY 2020 FY 2020 (Pro-forma Article 104a) FY 2021 Pillar 1 CET1 4.50% 4.50% 4.50% 4.50% Pillar 2 Requirement (P2R) " (1) 3.00% 1.69% 3.00% 1.69% Capital conservative buffer (CCB) 2.50% 2.50% 2.50% 2.50% Other systemically important institution (OSII) 1.00% 1.00% 1.50% 1.50% Counter cyclical buffer (CCYB) 0.00% 0.00% 0.00% 0.00% CET 1 11.00% 9.69% 11.50% 10.19% AT1 1.50% 2.06% 1.50% 2.06% Tier2 Total capital 2.00% 2.75% 2.00% 2.75% 14.50% 14.50% 15.00% 15.00% 蛋 AIB (1) In early 2020 P2R was required to be filled with CET1 only; post 8th April 2020 at least 56.25% (1.69% of RWA) of P2R must be CET1. Once AIB has fully filled its AT1 and T2 buckets the potential P2R composition as permitted by Article 104a shall include hybrid capital as follows: Current P2R composition P2R 3.0% 100% CET1 Potential P2R composition P2R 1.69% CET1 0.56% AT1 0.75% Tier 2 Article 104a Hybrid debt composition AT1 bucket 1.5% to 2.06% Tier 2 bucket 2.0% to 2.75% 10 10#11Mitigating distribution risk - FY 2020 SREP 11%, AT1 1.50%, T2 2.00% Very strong buffers to MDA and robust ADI capacity CET1 MDA (Transitional, %) includes unfilled AT1/T2 18.6 CET1 MDA (Fully loaded, %) includes unfilled AT1/T2 16.2 CET1 MDA (Fully loaded, %) assumes AT1/T2 buckets filled AIB 7.1% 11.5 0.52 11.00 CET1 ratio MDA threshold 4.8% 16.2 11.4 0.36 11.00 5.2% 11.00 11.00 CET1 ratio MDA threshold CET1 ratio MDA threshold % Buffer to MDA CET1 requirement Unfilled AT1/Tier 2 bucket Very strong buffers to MDA: Q1 2020 CET1 ratio Transitional 18.6%: buffer to MDA of 7.1% RWA / €3.8bn CET1 (Trans) which includes AT1/T2 unfilled portion of 0.52% - Q1 2020 CET1 ratio Fully loaded 16.2%: buffer to MDA of 4.8% RWA / €2.6bn CET1 (FL) which includes AT1/T2 unfilled portion of 0.36%. If the AT1/T2 buckets are filled this buffer would increase to 5.2% RWA / €2.8bn CET1 (FL) Overtime AIB intends to fill its AT1 and Tier 2 buckets at AIB Group plc (HoldCo) in order to optimise its use of CET1 Robust ADI capacity in excess of €4.5bn as at 31 Mar 2020 AIB intends to give due consideration to the capital hierarchy in the face of possible distribution restrictions stemming from any MDA or ADI limitations. However, AIB may deviate from this approach in its sole discretion 11#12Mitigating distribution risk - Pro-forma Article 104a SREP 9.69%, AT1 2.06%, T2 2.75% Very strong buffers to MDA and robust ADI capacity CET1 MDA (Transitional, %) includes unfilled AT1/T2 CET1 MDA (Fully loaded, %) includes unfilled AT1/T2 CET1 MDA (Fully loaded, %) assumes AT1/T2 buckets filled AIB 18.6 7.1% 11.5 1.83 9.69 CET1 ratio MDA threshold 16.2 4.8% 16.2 6.5% 11.4 9.69 1.67 9.69 9.69 CET1 ratio MDA threshold CET1 ratio MDA threshold % Buffer to MDA CET1 requirement Unfilled AT1/Tier 2 bucket Very strong buffers to MDA: Q1 2020 – CET1 ratio Transitional 18.6%: Buffer to MDA of 7.1% RWA / €3.8bn CET1 (Trans) which includes AT1/T2 unfilled portion of 1.83% Q1 2020-CET1 ratio Fully loaded 16.2%: Buffer to MDA of 4.8% RWA / €2.6bn CET1 (FL) which includes AT1/T2 unfilled portion of 1.67%. If the AT1/T2 buckets are filled this buffer would increase to 6.5% RWA / €3.5bn CET1 (FL) Over time AIB intends to fill its AT1 and Tier 2 buckets at AIB Group plc (HoldCo) in order to optimise its use of CET1 Robust ADI capacity in excess of €4.5bn as at 31 Mar 2020 AIB intends to give due consideration to the capital hierarchy in the face of possible distribution restrictions stemming from any MDA or ADI limitations. However, AIB may deviate from this approach in its sole discretion 12#13Summary Term Sheet AIB Group plc Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write Down Securities (the "Securities") Issuer Description Ranking Exp. Issue Ratings " Ba2 by Moody's Direct, unsecured, unguaranteed and deeply subordinated obligations of the Issuer and rank pari passu, without any preference, among themselves and with Other Pari Passu Instruments, ahead of all other classes of issued shares of the Issuer, but ranking junior to the claims of Senior Creditors AIB Currency / Size Maturity Optional Redemption Interest Interest Cancellation " Write Down Write up Special Event Redemption " Substitution/Variation Bail-in Governing Law Listing/Denom. EUR [] million Perpetual Non-Call [•] The Issuer may, in its sole and full discretion but subject to conditions (including Supervisory Permission) redeem all (but not some only) of the Securities on (i) any day falling in the period commencing on (and including) the date six months prior to the First Reset Date and ending on (and including) the First Reset Date or (ii) on any Interest Payment Date thereafter Fixed []% until First Reset Date, payable semi-annually in arrear on [] June and [] December in each year beginning on [❤] December 2020 Thereafter resets every 5 years to a rate equal to the sum of the then prevailing 5-year EUR mid-swap rate (subject to any Benchmark Event) + the margin (no step-up) (with such sum converted from an annual to a semi-annual basis) The Issuer may elect at its sole and full discretion to cancel (in whole or in part) any interest payment on any Interest Payment Date Mandatory cancellation upon insolvency of the Issuer, insufficient Distributable Items, the occurrence of a Trigger Event, or any Maximum Distributable Amount restrictions If, at any time, AIB Group plc or the Competent Authority determines that the CET1 Ratio of the Group has fallen below 7.0%, the then Prevailing Principal Amount of each Security shall be automatically and irrevocably reduced by the Write Down Amount necessary to restore the CET1 ratio to 7.0% To the extent permitted by Regulatory Capital Requirements and subject to any Maximum Distributable Amount, the Issuer shall have full discretion to reinstate any portion of any Written Down Security, which has been Written Down and which has not previously been Written Up, on a pro rata basis with all Written Down Additional Tier 1 Instruments (if any), and subject to certain conditions including the Maximum Write Up Amount Subject to certain conditions (including Supervisory Permission), in whole (but not in part), upon the occurrence of a Tax Event (Additional Amounts and Deductibility) or Capital Disqualification Event (partial or whole), at par Subject to certain conditions (including Supervisory Permission), upon the occurrence of a Tax Event (Additional Amounts and Deductibility) or Capital Disqualification Event, the Issuer may substitute or vary the terms of the Securities (all but not some only) so that they remain, or as appropriate become, Compliant Securities Statutory Irish bail in powers Laws of Ireland Euronext Dublin - GEM / €200k 13 See Preliminary Listing Particulars dated 16 June 2020 for detailed terms and conditions#14Tender offer Summary Terms Offer Offeror Target Securities Purchase Price Allocation of New AT1 Securities New Financing Condition Rationale ☐ Tender offer targeting up to €250mm in aggregate principal amount Allied Irish Banks, p.l.c. AIB €500mm Additional Tier 1 Perpetual Contingent Temporary Write-Down Securities (ISIN: XS1328798779), with a first reset date (being the first date on which, subject to obtaining regulatory consent and the satisfaction of certain other conditions, the issuer can elect to redeem such securities) of 3-Dec-2020. [x] % (together with Accrued Interest) When considering allocation of the New AT1 Securities, AIB Group plc intends to give preference to those Securityholders who, prior to such allocation, have validly tendered (or have given a firm indication to AIB Group plc or any Dealer Manager that they intend to tender) their Securities pursuant to the Offer. Please refer to the Tender Offer Memorandum for full details regarding the New AT1 Securities Allocation Purchase of any Securities validly tendered in the Offer is subject, without limitation, to the successful completion (in the sole determination of the Offeror) of the issue of the New Additional Tier 1 Securities The purpose of the Offer is to provide liquidity to holders and it is being made as part of the Offeror's active management of the AIB Group plc's consolidated capital profile whilst issuing New Additional Tier 1 securities ultimately for the benefit of the Offeror's business. Securities purchased by the Offeror pursuant to the Offer (and subject to satisfaction or waiver of the New Financing Condition on or prior to the Settlement Date) are expected to be cancelled and will not be re-issued or re-sold Commencement of the Offer: 16 June 2020 Expected timetable of events Expiration Deadline: 4.00pm on 22 June 2020 (all times are London time) ☐ Announcement of Results: At or around 10.00 a.m. on 23 June 2020 Settlement Date: expected on 24 June 2020 Dealer Managers BofA Securities, Goldman Sachs International, J.P. Morgan Note: Allocation of New AT1 securities - AIB Group plc is not obliged to allocate the New Additional Tier 1 Securities to a Securityholder who has validly tendered or indicated a firm intention to tender the Securities pursuant to the Offer. Any potential allocation of New Additional Tier 1 Securities, while being considered by AIB Group as set out above, will be made in accordance with customary new issue allocation processes and procedures. Offer restrictions apply. For further details please review the Tender Offer Memorandum dated 16 June 2020. 14#15Q1 2020 Trading and Covid-19 Update AIB Group plc AIB#16Q1 Trading and Covid-19 update COVID-19 response Financially and operationally resilient; backing our customers, staff and the Irish economy through the COVID-19 crisis Introduction of a wide range of customer initiatives; close to 50,000 payment breaks implemented Over 7,000 of our c. 9,500 staff are working remotely Our branch network remains open to serve the community AIB Pledged €2.4m to Trinity College Dublin to accelerate the immunology project and provided additional commitment to our Community Investment Programme, AIB Together Financial Highlights " Solid income performance: Q1 net interest income 5% lower than prior year; Q1 net interest margin (NIM) of 2.19% (Q4 exit NIM: 2.25%) Ongoing focus on cost discipline: Modest growth in costs, as expected, due to depreciation Increase in credit provisioning: Q1 ECL charge of €210m (136bps annualised cost of risk), primarily reflecting changes in macroeconomic assumptions due to COVID-19 impact with further impact of the crisis expected to be felt in Q2 Mixed new lending performance: Strong new lending in Retail Banking with 11% growth in mortgages and increased market share of 32.9% (¹), overall new lending was 12% lower than Q1 2019 principally due to lower international lending Strong capital and liquidity positions: Fully loaded pro-forma CET1 16.2% (2), >500bps buffer to Maximum Distributable Amount (MDA) and well in excess of our target CET1 level of >14% (1) Source: Mortgage drawdowns ytd BPFI March 2020 (2) Pro-forma FL CET1 16.2% and pro-forma Transitional CET1 18.6% both include 90bps indicative TRIM impact for AIB mortgage model and 40bps for cancelled 2019 dividend €217m 16#17Q1 Trading and Covid-19 update continued AIB Outlook Medium term targets outlined on 6 March 2020 remain appropriate; Guidance related to 2020 expected performance is no longer current The Group remains financially and operationally resilient amid heightened uncertainty Our strong capital and funding position enables us to support our customers and aid the economic recovery efforts Please see link below to our most recent market announcement on 12 May 2020 on Q1 2020 Trading and Covid-19 update https://aib.ie/content/dam/aib/investorrelations/docs/se-announcements/2019/aib-group-plc-q3-2019-trading-update.pdf 17#18Breakdown of loan book by sector and stage Q1 2020 5.7% loans are classified as Stage 3 / Purchased or originated credit impaired (POCI) Gross Loans and advances to customers (at amortised cost) at end Q1 €m Analysed by ECL stage profile Stage 1 Stage 2 Stage 3 POCI Total Agriculture Enery 1,436 228 102 0 1,766 1,529 19 4 1,553 Manufacturing 2,871 149 57 0 3,077 Property and construction 6,372 443 418 0 7,234 Distribution 4,282 682 241 0 5,205 Transport 1,761 82 47 0 1,890 Financial 620 13 3 0 636 Other services 5,138 543 140 0 5,821 Personal: Residential mortgages 26,747 2,250 2,084 192 31,273 Personal: Other 2,263 371 222 0 2,856 Total 53,021 4,780 3,318 192 61,311 % Stage composition 86.5% 7.8% 5.4% 0.3% 100% AIB 18#19Credit ratings Investment grade status for AIB Group plc MOODY'S Fitch Ratings AIB Group plc (Hold Co) Baa2 BBB Long Term Issuer Rating Outlook Investment Grade STANDARD & POOR'S BBB- Stable Negative Negative AIB 19#20Medium term targets (2022) Medium-term targets by 2022 Focused cost (1) discipline €1.5bn 123 1) Costs before bank levies and regulatory fees and exceptional items 2) Fully loaded 3) ROTE (PAT AT1)/(CET1 @ 14% of RWAs) וחו Appropriate capital target CET1 (2) > 14% Deliver sustainable returns ROTE (3) > 8% AIB 20 20#21Contacts Please contact Investor Relations or Treasury Funding Team for any further information Name Niamh Hore Email [email protected] Telephone +353 1 6411817 Head of IR Janet McConkey Head of Debt IR Siobhain Walsh Investor Relations Mark Whelan [email protected] +353 1 6418974 [email protected] +353 1 6411901 / +353 87 395 6864 [email protected] +353 1 6417164 / +353 87 284 8714 Head of Term Funding Eoin Moore Term Funding [email protected] +353 1 6417803 / +353 87 954 1834 Visit our website at aib.ie/investorrelations AIB 21